Market Overview

J.R. Simplot Company Secures Agricultural Research and Commercial License from Corteva Agriscience™ and Broad Institute of MIT and Harvard

Share:

J.R. Simplot Company Secures Agricultural Research and Commercial License from Corteva Agriscience™ and Broad Institute of MIT and Harvard

Potential benefits include higher yields, improved environmental impact and reduced food waste

PR Newswire

BOISE, Idaho, Aug. 6, 2018 /PRNewswire/ -- The J.R. Simplot Company announced today that it has executed a joint intellectual property licensing agreement with Corteva Agriscience, Agriculture Division of DowDuPont, and the Broad Institute of MIT and Harvard for foundational CRISPR-Cas9 and related gene editing tools. The technology provides Simplot with another avenue to bring desirable traits forward in certain fruits and vegetables and advance products to the market in the United States to benefit both farmers and consumers. Simplot provides a full line of fresh, frozen and chilled offerings that include potatoes, avocados and strawberries.

Using gene editing technology such as CRISPR-Cas9, bruising and browning of potatoes can be reduced, eliminating some of the 3.6 billion lbs. of potato food waste each year. © 2018 J.R. Simplot Company

Each year, 35 percent of fresh potatoes worth $1.7 billion are lost because of waste from poor storage or shelf life according to the Journal of Consumer Affairs. Avocados, strawberries and other fruits and vegetables have similar losses and gene editing technology like CRISPR-Cas9 genome editing tools may be able to reduce that significantly.

"We're excited to add CRISPR-Cas9 technology to our platform of tools aimed at providing more sustainable produce for the industry," said Susan Collinge PhD, Vice President of Simplot Plant Sciences. "These pioneering tools may enable growers to achieve higher yields on less land resulting in fewer pesticides, water and labor needs while extending the quality of a consumer's favorite foods."

Comprehensive intellectual property rights allow entities to apply scientific tools as widely as possible. To enable such access, Corteva Agriscience and Broad Institute have agreed on a joint non-exclusive licensing framework for agricultural use. The license to Simplot represents the first time that Corteva Agriscience and Broad Institute have jointly provided a license of CRISPR-Cas9 genome editing tools to an agricultural company.

"We applaud Simplot for taking the initiative to broaden their portfolio of food technologies to further enhance sustainability and reduce food waste," said Neal Gutterson, Chief Technology Officer at Corteva Agriscience. "CRISPR-Cas9 offers farmers and consumers so many great benefits. It's exciting to see a company with such a strong innovation track record putting CRISPR-Cas9 to work."

Simplot is one of the largest potato processors in North America and processes a variety of fruits and vegetables around the world. Using different genetic techniques, the company previously commercialized two generations of its Innate®-branded line of potato varieties by adapting genes only from wild and cultivated potatoes. The potatoes feature reduced bruising and black spots, reduced natural asparagine and protection from late blight pathogens.

"Our goal is to maximize the scientific impact of CRISPR-Cas9 for improving agriculture, and our joint licensing agreement offers the opportunity to provide much broader access to help researchers reduce food waste, limit pesticides, and improve drought resistance, while promoting safe and ethical uses of groundbreaking technologies," said Issi Rozen, Chief Business Officer of the Broad Institute.

The U.S. Department of Agriculture (USDA) recently issued a statement providing clarification on plants produced through innovative new breeding techniques which include CRISPR-Cas9 genome editing techniques. Under its biotechnology regulations, USDA does not regulate or have any plans to regulate plants that could otherwise have been developed through traditional breeding techniques as long as they are not plant pests or developed using plant pests.

Learn more about CRISPR-Cas9 applications in agriculture at http://crisprcas.pioneer.com.

Learn more about the Broad Institute's efforts to offer CRISPR tools for agriculture at https://www.broadinstitute.org/.

About Simplot
The J.R. Simplot Company, a privately held agribusiness firm headquartered in Boise, Idaho, has an integrated portfolio that includes phosphate mining, fertilizer manufacturing, farming, ranching and cattle production, food processing, food brands, and other enterprises related to agriculture. Simplot's major operations are located in the U.S., Canada, Mexico, Australia, and China, with products marketed in more than 40 countries worldwide. The company's mission statement is Bringing Earth's Resources to Life.

Learn more about Simplot at Simplot.com.

Learn more about Innate Potatoes at http://www.innatepotatoes.com.

About Corteva Agriscience™, Agriculture Division of DowDuPont
Corteva Agriscience™, Agriculture Division of DowDuPont (NYSE:DWDP), is intended to become an independent, publicly traded company when the previously announced spinoff is complete by June 2019. The division combines the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences. Corteva Agriscience™ provides growers around the world with the most complete portfolio in the industry — including some of the most recognized brands in agriculture: Pioneer®, Encirca®, the newly launched Brevant™ Seeds, as well as award-winning Crop Protection products — while bringing new products to market through our solid pipeline of active chemistry and technologies. More information can be found at www.corteva.com.

Follow Corteva Agriscience™, Agriculture Division of DowDuPont, on Facebook, Instagram, LinkedIn, Twitter and YouTube.

About the Broad Institute of MIT and Harvard
Broad Institute of MIT and Harvard was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods, and data openly to the entire scientific community.

Founded by MIT, Harvard, Harvard-affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff, and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/jr-simplot-company-secures-agricultural-research-and-commercial-license-from-corteva-agriscience-and-broad-institute-of-mit-and-harvard-300691960.html

SOURCE J.R. Simplot Company

View Comments and Join the Discussion!